Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human IMPA1 ELISA Kit (AC3174)
Cat.#: ASET-1763
Specifications
Description Human IMPA1 ELISA Kit allows for the in vitro quantitative determination of human IMPA1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2434 Human GAB2 ELISA Kit (AC3845) Quantitative inquiry ASET-1787 Human UCP3 ELISA Kit (AC3198) Quantitative inquiry ASET-1446 Human Semaphorin 7a ELISA Kit (AC2857) Quantitative inquiry ASET-2510 Mouse beta 1 Adrenergic Receptor ELISA Kit (AC3921) Quantitative inquiry ASET-1006 Mouse SHC ELISA Kit (AC2417) Quantitative inquiry ASET-1610 Human Orexin A ELISA Kit (AC3021) Quantitative inquiry ASET-1341 Chicken Acetylcholinesterase ELISA Kit (AC2752) Quantitative inquiry ASET-1528 Human Semaphorin 3F ELISA Kit (AC2939) Quantitative inquiry ASET-1061 Human ProSAAS ELISA Kit (AC2472) Quantitative inquiry ASET-2224 Human Apelin ELISA Kit (AC3635) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket